Does RAMUCIRUMAB Cause Lung neoplasm malignant? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Lung neoplasm malignant have been filed in association with RAMUCIRUMAB (CYRAMZA). This represents 0.2% of all adverse event reports for RAMUCIRUMAB.
12
Reports of Lung neoplasm malignant with RAMUCIRUMAB
0.2%
of all RAMUCIRUMAB reports
5
Deaths
0
Hospitalizations
How Dangerous Is Lung neoplasm malignant From RAMUCIRUMAB?
Of the 12 reports, 5 (41.7%) resulted in death.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAMUCIRUMAB. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does RAMUCIRUMAB Cause?
Malignant neoplasm progression (743)
Death (492)
Interstitial lung disease (269)
Febrile neutropenia (229)
Neutropenia (229)
Decreased appetite (187)
Diarrhoea (186)
Hypertension (175)
Pyrexia (161)
Nausea (160)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which RAMUCIRUMAB Alternatives Have Lower Lung neoplasm malignant Risk?
RAMUCIRUMAB vs RANEXA
RAMUCIRUMAB vs RANIBIZUMAB
RAMUCIRUMAB vs RANIMUSTINE
RAMUCIRUMAB vs RANITIDINE
RAMUCIRUMAB vs RANITIDINE\RANITIDINE